HomeRAPH • OTCMKTS
add
Raphael Pharmaceutical Inc
Nakaraang pagsara
$1.65
Sakop ng taon
$0.60 - $1.67
Market cap
30.79M USD
Average na Volume
55.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 547.00K | 112.02% |
Net na kita | -550.00K | -108.33% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 287.00K | 655.26% |
Kabuuang asset | 353.00K | 135.33% |
Kabuuang sagutin | 456.00K | 186.79% |
Kabuuang equity | -103.00K | — |
Natitirang share | 18.66M | — |
Presyo para makapag-book | -165.00 | — |
Return on assets | -395.23% | — |
Return on capital | -1,667.68% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -550.00K | -108.33% |
Cash mula sa mga operasyon | -172.00K | 56.89% |
Cash mula sa pag-invest | -1.00K | — |
Cash mula sa financing | 230.00K | 54.36% |
Net change in cash | 57.00K | 122.80% |
Malayang cash flow | 83.25K | 127.75% |
Tungkol
Itinatag
2007
Headquarters
Website